Excessive Daytime Somnolence: Clinical Trials

1 trial for Excessive Daytime Somnolence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Excessive Daytime Somnolence: new trials by email Literature Review of Excessive Daytime Somnolence trials Research Report on Excessive Daytime Somnolence

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluate SunosiĀ® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration
Solriamfetol 150 mg Oral Tablet - Narcolepsy, Obstructive Sleep Apnea
Phase 1CompletedAxsome Therapeutics, Inc.62021-08-272023-04-14

Narrower conditions

Disorders of Excessive Somnolence (1)  ·  Narcolepsy (1)  ·  Sleep Apnea, Obstructive (1)

Broader conditions

Apnea (1)  ·  Dyssomnias (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)  ·  Sleep Apnea Syndromes (1)  ·  Sleep Disorders, Intrinsic (1)  ·  Sleep Wake Disorders (1)

Interventions

Tablets (1)  ·  solriamfetol (1)

Sponsors

Axsome Therapeutics, Inc. (1)

Countries

United States (1)